Antonio S. Montecalvo

CIK: 0001759261

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)10 (71.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ORGO

Organogenesis Holdings Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

ORGO
Organogenesis Holdings Inc.
Feb 18, 2026
Award(A)
Direct
11.3K shares-
ORGO
Organogenesis Holdings Inc.
Feb 18, 2026
Tax Payment(F)
Direct
3.8K shares at avg. $3.84$15K
ORGO
Organogenesis Holdings Inc.
Feb 18, 2026
Award(A)
Direct
11.2K shares-
ORGO
Organogenesis Holdings Inc.
Feb 18, 2026
Tax Payment(F)
Direct
3.7K shares at avg. $3.84$14K
ORGO
Organogenesis Holdings Inc.
Feb 18, 2026
Award(A)
Direct
40.6K shares-
ORGO
Organogenesis Holdings Inc.
Feb 15, 2026
Tax Payment(F)
Direct
9.6K shares at avg. $3.73$36K
ORGO
Organogenesis Holdings Inc.
Feb 15, 2026
Tax Payment(F)
Direct
4.1K shares at avg. $3.73$15K
ORGO
Organogenesis Holdings Inc.
Feb 15, 2026
Tax Payment(F)
Direct
3.5K shares at avg. $3.73$13K
ORGO
Organogenesis Holdings Inc.
Feb 15, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $3.73$5K
ORGO
Organogenesis Holdings Inc.
Feb 19, 2025
Award(A)
Direct
42.5K shares-
ORGO
Organogenesis Holdings Inc.
Feb 16, 2025
Tax Payment(F)
Direct
719 shares at avg. $3.70$3K
ORGO
Organogenesis Holdings Inc.
Feb 15, 2025
Tax Payment(F)
Direct
1.3K shares at avg. $3.70$5K
ORGO
Organogenesis Holdings Inc.
Feb 15, 2025
Tax Payment(F)
Direct
8.7K shares at avg. $3.70$32K
ORGO
Organogenesis Holdings Inc.
Feb 15, 2025
Tax Payment(F)
Direct
3.5K shares at avg. $3.70$13K

		Type	Shares	Price		Ownership
Feb 18, 2026	ORGO Organogenesis Holdings Inc.	Award(A)	11,330	-	$0	Direct
Feb 18, 2026	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	3,778	$3.84	$14,508	Direct
Feb 18, 2026	ORGO Organogenesis Holdings Inc.	Award(A)	11,218	-	$0	Direct
Feb 18, 2026	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	3,741	$3.84	$14,365	Direct
Feb 18, 2026	ORGO Organogenesis Holdings Inc.	Award(A)	40,625	-	$0	Direct
Feb 15, 2026	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	9,607	$3.73	$35,834	Direct
Feb 15, 2026	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	4,100	$3.73	$15,293	Direct
Feb 15, 2026	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	3,523	$3.73	$13,141	Direct
Feb 15, 2026	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	1,389	$3.73	$5,181	Direct
Feb 19, 2025	ORGO Organogenesis Holdings Inc.	Award(A)	42,493	-	-	Direct
Feb 16, 2025	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	719	$3.70	$2,660	Direct
Feb 15, 2025	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	1,252	$3.70	$4,632	Direct
Feb 15, 2025	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	8,657	$3.70	$32,031	Direct
Feb 15, 2025	ORGO Organogenesis Holdings Inc.	Tax Payment(F)	3,453	$3.70	$12,776	Direct

1-14 of 14 transactions

About Montecalvo Antonio S.

Montecalvo Antonio S. (SEC CIK 0001759261) files insider reports with the SEC as Vice President, Health Policy of Organogenesis Holdings Inc. (ORGO).

Signal8 holds 5 ownership filings by Montecalvo Antonio S., all Form 4s, filed between Feb 19, 2025 and Mar 3, 2026. Those filings report 14 transactions, from Feb 15, 2025 to Feb 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Montecalvo Antonio S.'s filings is in CANTON, MA.

Recent filings by Montecalvo Antonio S.

Feb 18, 2026: Grant or award of ORGO shares (Form 4, code A).
Feb 18, 2026: Tax withholding of ORGO shares (Form 4, code F).
Feb 18, 2026: Grant or award of ORGO shares (Form 4, code A).
Feb 18, 2026: Tax withholding of ORGO shares (Form 4, code F).
Feb 18, 2026: Grant or award of ORGO shares (Form 4, code A).

Other insiders filing for Organogenesis Holdings Inc. (ORGO)

Grow Brian, Chief Commercial Officer
Leibowitz Arthur S, Director
Driscoll Michael Joseph, Director
Cavorsi Robert, Vice President, Strategy
Gillheeney Gary S., President and CEO
Bilbo Patrick, Chief Operating Officer

How to read Form 4 transaction codes